Precision BioSciences, Inc. (DTIL)

NASDAQ: DTIL · IEX Real-Time Price · USD

9.41

-0.48 (-4.85%)

At close: Jul 2, 2024, 4:00 PM

9.81

+0.40 (4.22%)

After-hours: Jul 2, 2024, 5:51 PM EDT

Precision BioSciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2017
Net Income	-61.32	-111.64	-30.6	-109.01	-92.88	Upgrade
Depreciation & Amortization	8.26	9	10.2	9.81	5.32	Upgrade
Share-Based Compensation	14.04	19.2	16.51	13.79	8.94	Upgrade
Other Operating Activities	-45.09	37.68	-6.96	-1.98	7.61	Upgrade
Operating Cash Flow	-84.11	-45.75	-10.85	-87.39	-71.02	Upgrade
Capital Expenditures	-1.85	-3.32	-5.05	-5.03	-24.67	Upgrade
Acquisitions	8	0	0	0	0	Upgrade
Other Investing Activities	-0.32	-	-0.75	-	-	Upgrade
Investing Cash Flow	5.83	-3.32	-5.8	-5.03	-24.67	Upgrade
Share Issuance / Repurchase	5.39	75.18	61.28	1.33	136.45	Upgrade
Debt Issued / Paid	0	19.81	2.46	0	39.55	Upgrade
Other Financing Activities	-	-	6.78	-	-2.62	Upgrade
Financing Cash Flow	5.39	94.99	70.52	1.33	173.37	Upgrade
Net Cash Flow	-72.9	45.91	53.87	-91.09	77.69	Upgrade
Free Cash Flow	-85.96	-49.07	-15.91	-92.42	-95.68	Upgrade
Free Cash Flow Margin	-176.42%	-195.52%	-13.77%	-380.55%	-430.26%	Upgrade
Free Cash Flow Per Share	-22.38	-16.75	-8.13	-53.28	-68.36	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).